Drug use and prescribing problems in four state Medicaid programs.
In this article the authors present population-level prevalence rates for 61 specific drug-related problems occurring in three State Medicaid programs (Maryland, Iowa, and Washington) from 1989 through 1996 and a fourth (Georgia) from 1994 through 1996. The findings represent the first application of a consistent drug utilization review (DUR) screener program to Medicaid data across States. The study finds major differences in DUR failure rates among the four States with the lowest rates in Georgia and the highest in Washington. Only Iowa showed any population-level reduction in DUR failure rates during the study period, however, rates for community-dwelling elderly fell in most States.
Stuart
B
B
University of Maryland School of Pharmacy, Baltimore 21201, USA. bstuart@rx.umaryland.edu
Briesacher
B A
BA
Ahern
F
F
Kidder
D
D
Zacker
C
C
Erwin
G
G
Gilden
D
D
Fahlman
C
C
D004358:Drug Therapy / Q000145:classification; D004363:Drug Utilization / Q000706:statistics & numerical data*; D064420:Drug-Related Side Effects and Adverse Reactions; D005845:Georgia; D006302:Health Services Research; D006801:Humans; D007345:Insurance Claim Review; D007484:Iowa; D008396:Maryland; D008484:Medicaid / Q000706:statistics & numerical data*; D013221:State Health Plans / Q000458:organization & administration; D014481:United States; D014861:Washington